TARGIT-DCIS
Background
Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma in Situ of the Breast also known as the TARGIT-DCIS Trial is a phase II clinical trial designed to examine the safety and efficacy of intraoperative radiotherapy (IORT) for the management of DCIS.
The study began in 2007 and has completed recruitment and analysis.
Primary Objective
To determine if patients with pure DCIS considered eligible for concurrent
IORT at the time of surgery based on preoperative mammography and contrast-enhanced magnetic resonance imaging (CE-MRI) could be successfully treated using IORT with minimal need for additional therapy due to inadequate surgical margins or excessive tumor size.
Study Status
Recruitment Completed, Results Published, Follow-Up Ongoing
Sponsors and Collaborators
Helen Rey Breast Cancer Research Foundation
Clinical Trials.gov Identifier
NCT00556907
Study Contact
Allison Zimmerman
Research Coordinator
Helen Rey Breast Cancer Research Foundation
Telephone: 818-539-1985 Fax: 818-539-1985